Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation
Authors:
Open Access
- 8 April 2007
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 20 (7) , 576-582
Abstract
The aim of this study was to evaluate the hypothesis that the detection of alpha-fetoprotein (AFP) mRNA-expressing cells could be a novel, direct and accurate method for predicting tumor recurrence after living donor liver transplantation (LDLT) in patients with hepatocellular carcinoma (HCC). The test group consisted of 32 patients who underwent LDLT for end-stage liver disease with HCC. Quantitative real-time reverse transcription polymerase chain reaction was used for the detection of AFP mRNA-expressing cells in the peripheral blood. Nine (28.1%) of the 32 patients developed tumor recurrences during the follow-up period (mean, 27.9 months). The test for the presence of AFP mRNA in the peripheral blood was positive either preoperatively or postoperatively in 11 (34.3%) of the 32 patients, and positive preoperatively in three patients (9.4%). Univariate analysis revealed that a positive preoperative test for peripheral blood AFP mRNA, as well as exceeding Milan criteria and microscopic evidence of vascular invasion were significant predictors for the recurrence of HCC (P = 0.002, 0.049, and 0.001, respectively). Multivariate analysis using Cox's proportional hazards model revealed that a positive preoperative test for peripheral blood AFP mRNA was an independent risk factor for the recurrence of HCC. We concluded that the presence of AFP mRNA-expressing cells preoperatively could be a useful predictor of the recurrence of HCC in liver transplant patients.Keywords
This publication has 11 references indexed in Scilit:
- Association Between Recurrence of Hepatocellular Carcinoma and α-Fetoprotein Messenger RNA Levels in Peripheral BloodSurgery Today, 2005
- Circulating Messenger RNA of α-FetoproteinArchives of Surgery, 2004
- Living Donor Liver Transplantation for Adult Patients With Hepatocellular CarcinomaAnnals of Surgery, 2004
- Operative morbidity of living liver donors in JapanThe Lancet, 2003
- Liver transplantation in association with hepatocellular carcinoma: An update of the international tumor registryLiver Transplantation, 2002
- Adult-to-Adult Transplantation of the Right Hepatic Lobe from a Living DonorNew England Journal of Medicine, 2002
- α-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: A prospective studyHepatology, 2002
- Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact SurvivalHepatology, 2001
- Postoperative detection of α‐fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2001
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisNew England Journal of Medicine, 1996